Home > Healthcare > Pharmaceuticals > Finished Drug Form > Female Sexual Dysfunction Treatment Market

Female Sexual Dysfunction Treatment Market Size

Report ID: GMI9138
Published Date: Apr 2024
Report Format: PDF

Download Free Sample

Female Sexual Dysfunction Treatment Market Size

Female Sexual Dysfunction Treatment Market size was valued at around USD 495.3 million in 2023 and is estimated to grow at 10% CAGR from 2024 to 2032. Female sexual dysfunction (FSD) treatment refers to the various medical, psychological, and lifestyle interventions aimed at addressing a range of sexual health issues and dysfunctions experienced by women.

Female Sexual Dysfunction Treatment Market

To get key market trends

Download Free Sample

FSD encompasses difficulties related to sexual desire, arousal, orgasm, and satisfaction that cause distress or interpersonal difficulties. Treatment approaches for FSD are personalized to each individual's needs and may include psychotherapy, hormonal therapy, medications such as phosphodiesterase inhibitors, pelvic floor exercises, couples therapy, sexual health testing, education and counseling, and lifestyle modifications.

Female Sexual Dysfunction Treatment Market Report Attributes
Report Attribute	Details
Base Year:	2023
Female Sexual Dysfunction Treatment Market Size in 2023:	USD 495.3 Million
Forecast Period:	2024 - 2032
Forecast Period 2024 - 2032 CAGR:	10%
2032 Value Projection:	USD 1.1 Billion
Historical Data for:	2021 – 2023
No. of Pages:	210
Tables, Charts & Figures:	282
Segments covered:	Drug, Disease, Route of Administration, Distribution Channel, and Region
Growth Drivers:	Increasing awareness regarding female sexual health issues Growing focus towards womens health Rising research & development activities Increasing advancements in medical technology
Pitfalls & Challenges:	Societal stigma and taboos associated with female sexual heath High treatment costs

Learn more about the key segments shaping this market

Download Free Sample

The increasing advancements in medical technology in the field of female sexual dysfunction (FSD) treatment is a significant driving factors for the market. Furthermore, increasing awareness regarding female sexual health issues, growing focus towards women's health, and rising research & development activities, are the promoting factors fostering the growth of the market.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Female sexual dysfunction treatment market size was USD 495.3 million in 2023 and is expected to register 10% CAGR from 2024-2032 owing to the increasing advancements in medical technology in the field of female sexual dysfunction (FSD) treatment worldwide.

The estrogen therapy segment is expected to reach USD 797.2 million by 2032 due to its capability to help alleviate vaginal dryness, itching, and discomfort which are common symptoms of FSD.

The U.S. female sexual dysfunction treatment industry is expected to register 9.7% CAGR from 2024-2032 due to well-developed healthcare infrastructure with modern facilities, advanced medical technology, and highly trained healthcare professionals in the region.

Cipla Limited, Freya Pharma Solutions, GSK plc, Lawley Pharmaceuticals Pty Ltd., Merck & Co., Inc., Millicent Pharma Limited, Novo Nordisk, Pfizer, Inc., and Sprout Pharmaceuticals, Inc., are some of the major female sexual dysfunction treatment companies worldwide.